8-41797691-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The ENST00000265709.14(ANK1):​c.127-39554G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,200,424 control chromosomes in the GnomAD database, including 209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.016 ( 28 hom., cov: 32)
Exomes 𝑓: 0.018 ( 181 hom. )

Consequence

ANK1
ENST00000265709.14 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:2

Conservation

PhyloP100: -0.289

Publications

4 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 8-41797691-C-T is Benign according to our data. Variant chr8-41797691-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 512.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.016 (2438/152206) while in subpopulation NFE AF = 0.0182 (1238/67994). AF 95% confidence interval is 0.0174. There are 28 homozygotes in GnomAd4. There are 1139 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK1NM_000037.4 linkc.-153G>A upstream_gene_variant ENST00000289734.13 NP_000028.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK1ENST00000289734.13 linkc.-153G>A upstream_gene_variant 1 NM_000037.4 ENSP00000289734.8

Frequencies

GnomAD3 genomes
AF:
0.0160
AC:
2426
AN:
152090
Hom.:
27
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0177
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0132
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.000196
Gnomad SAS
AF:
0.00393
Gnomad FIN
AF:
0.0190
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0182
Gnomad OTH
AF:
0.00860
GnomAD4 exome
AF:
0.0185
AC:
19358
AN:
1048218
Hom.:
181
AF XY:
0.0180
AC XY:
9183
AN XY:
511456
show subpopulations
African (AFR)
AF:
0.0210
AC:
422
AN:
20140
American (AMR)
AF:
0.00975
AC:
125
AN:
12826
Ashkenazi Jewish (ASJ)
AF:
0.00528
AC:
83
AN:
15708
East Asian (EAS)
AF:
0.0000363
AC:
1
AN:
27582
South Asian (SAS)
AF:
0.00310
AC:
142
AN:
45866
European-Finnish (FIN)
AF:
0.0180
AC:
749
AN:
41636
Middle Eastern (MID)
AF:
0.00230
AC:
7
AN:
3044
European-Non Finnish (NFE)
AF:
0.0204
AC:
17086
AN:
837586
Other (OTH)
AF:
0.0170
AC:
743
AN:
43830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
891
1783
2674
3566
4457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
706
1412
2118
2824
3530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0160
AC:
2438
AN:
152206
Hom.:
28
Cov.:
32
AF XY:
0.0153
AC XY:
1139
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0179
AC:
746
AN:
41574
American (AMR)
AF:
0.0131
AC:
201
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5100
South Asian (SAS)
AF:
0.00394
AC:
19
AN:
4826
European-Finnish (FIN)
AF:
0.0190
AC:
202
AN:
10616
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.0182
AC:
1238
AN:
67994
Other (OTH)
AF:
0.00851
AC:
18
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
118
236
353
471
589
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0165
Hom.:
4
Bravo
AF:
0.0162
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE Pathogenic:1Benign:1
Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

NG_012820.1(NM_001142446.2):c.127-39554G>A in the ANK1 gene has an allele frequency of 0.02 in African subpopulation in the gnomAD database. 6 homozygous occurrences are observed in the gnomAD database. This variant was reported as -153G-A in a hereditary spherocytosis patient (PMID: 11102985). Benign computational verdict because benign prediction from DANN. Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BS2, BP4.

Dec 01, 2000
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

not provided Uncertain:1Benign:1
Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ANK1: BS1, BS2

May 19, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, BS2, BP4, BP7

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
3.3
DANN
Benign
0.88
PhyloP100
-0.29
PromoterAI
-0.069
Neutral
Mutation Taster
=100/0
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183894680; hg19: chr8-41655209; API